Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer
2014 ◽
Vol 20
(24)
◽
pp. 6284-6294
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 2531-2531
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 14521-14521
2011 ◽
Vol 18
(4)
◽
pp. 1092-1100
◽
2007 ◽
Vol 2
(8)
◽
pp. S458-S459